KRAS and neoplasm: Thus, the reduction in downstream MAPK signaling from KRASG12V/K147D, especially since it did not impair self-association of KRAS (Fig. 3), could be a consequence of the K147D mutation preventing these tumor-promoting posttranslational modifications.